{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:36Z","timestamp":1790393616340,"version":"4.1.0"},"reference-count":51,"publisher":"Impact Journals, LLC","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,6,7]]},"DOI":"10.18632\/oncotarget.8710","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T18:22:47Z","timestamp":1460485367000},"page":"34070-34083","source":"Crossref","is-referenced-by-count":42,"title":["Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Jinle","family":"Tang","sequence":"first","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Li","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jiangsu Provincial Traditional Chinese Medical Hospital, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yu","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[{"name":"Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyang","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingding","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"},{"name":"Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China"},{"name":"The Department of Lymphoma\/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[{"name":"Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishu","family":"Gong","sequence":"additional","affiliation":[{"name":"The Medical Group of Zhengzhou First People's Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jiangsu Provincial Traditional Chinese Medical Hospital, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Jiangsu Provincial Traditional Chinese Medical Hospital, Nanjing, Jiangsu Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Meng","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangli","family":"An","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[{"name":"The Cyrus Tang Hematology Center, Soochow University, Suzhou, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"},{"name":"Suzhou Cancer Immunotherapy and Diagnosis Engineering Center, Suzhou, China"},{"name":"The Department of Lymphoma\/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V98.4.1160","article-title":"Expression of functional lung resistance\u2014related protein predicts poor outcome in adult T-cell leukemia","volume":"98","author":"Akiyama","year":"2001","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Morishima","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cas.12617","article-title":"Recent advances in the treatment of adult T-cell leukemia-lymphomas","volume":"106","author":"Seto","year":"2015","journal-title":"Cancer Sci"},{"key":"4","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Matsushima","year":"2003","journal-title":"Clin Cancer Res"},{"key":"5","first-page":"18","article-title":"Choices in the treatment of cutaneous T-cell lymphoma","volume":"21","author":"Hymes","year":"2007","journal-title":"Oncology (Williston Park)"},{"key":"6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.blre.2007.03.001","article-title":"Peripheral T-cell lymphomas","volume":"21","author":"Savage","year":"2007","journal-title":"Blood Rev"},{"key":"7","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2014-01-492256","article-title":"Immunotoxins for leukemia","volume":"123","author":"Pastan","year":"2014","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1891","article-title":"Immunotoxin therapy of cancer","volume":"6","author":"Kreitman","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/j.1460-2075.1987.tb02651.x","article-title":"Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system","volume":"6","author":"Seed","year":"1987","journal-title":"EMBO J"},{"key":"10","first-page":"331","article-title":"Structure and function of the CD7 molecule","volume":"19","author":"Haynes","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.149.6.2110","article-title":"Expression of CD7 on normal human myeloid progenitors","volume":"149","author":"Torok-Storb","year":"1992","journal-title":"J Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4049\/jimmunol.152.2.517","article-title":"Expression and function of CD7 molecule on human natural killer cells","volume":"152","author":"Whiteside","year":"1994","journal-title":"J Immunol"},{"key":"13","first-page":"1","article-title":"Immunologic classification of leukemia and lymphoma","volume":"68","author":"Todd","year":"1986","journal-title":"Blood"},{"key":"14","first-page":"239","article-title":"Biological characteristics of CD7(+) acute leukemia","volume":"21","author":"Kita","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","article-title":"Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia","volume":"12","author":"Cordero","year":"1998","journal-title":"Leukemia"},{"key":"16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2567.1996.d01-744.x","article-title":"CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells","volume":"89","author":"Abken","year":"1996","journal-title":"Immunology"},{"key":"17","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.4049\/jimmunol.158.7.3259","article-title":"Construction and characterization of human CD7-specific single-chain Fv immunotoxins","volume":"158","author":"Pennell","year":"1997","journal-title":"J Immunol"},{"key":"18","first-page":"3056","article-title":"Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia","volume":"52","author":"Kung","year":"1992","journal-title":"Cancer Res"},{"key":"19","first-page":"5787","article-title":"Host-mediated antibody-dependent cellular cytotoxicity contributes to thetherapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia","volume":"58","author":"Flavell","year":"1998","journal-title":"Cancer Res"},{"key":"20","first-page":"1314","article-title":"Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7","volume":"52","author":"Kersey","year":"1992","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428199709051778","article-title":"Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin","volume":"26","author":"Vallera","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/bjc.1997.177","article-title":"Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule","volume":"75","author":"Flavell","year":"1997","journal-title":"Br J Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/excr.1993.1142","article-title":"Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome","volume":"206","author":"Vitetta","year":"1993","journal-title":"Exp Cell Res"},{"key":"24","first-page":"2848","article-title":"A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells","volume":"62","author":"Fey","year":"2002","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1200\/JCO.2011.38.1756","article-title":"Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia","volume":"30","author":"Pastan","year":"2012","journal-title":"J Clin Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers","year":"1993","journal-title":"Nature"},{"key":"27","first-page":"607","article-title":"Targeting tumors with nanobodies for cancer imaging and therapy","volume":"172","author":"van Bergen En Henegouwen","year":"2013","journal-title":"Cancer Res"},{"key":"28","first-page":"2853","article-title":"Efficient cancer therapy with a nanobody-based conjugate","volume":"64","author":"Revets","year":"2004","journal-title":"N Biotechnol"},{"key":"29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.nbt.2012.09.002","article-title":"Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth","volume":"30","author":"Muyldermans","year":"2013","journal-title":"New biotechnology"},{"key":"30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2012.11.007","article-title":"Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells","volume":"165","author":"Kok","year":"2013","journal-title":"J Control Release"},{"key":"31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biomaterials.2013.10.001","article-title":"Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles","volume":"35","author":"van Bergen en Henegouwen","year":"2014","journal-title":"Biomaterials"},{"key":"32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-3083.2003.01189.x","article-title":"Clonal analysis of a human antimouse antibody (HAMA) response","volume":"57","author":"Thompson","year":"2003","journal-title":"Scand J Immunol"},{"key":"33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"De Haard","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"34","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1073\/pnas.96.7.3957","article-title":"Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome","volume":"96","author":"Vitetta","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2008.20.2630","article-title":"Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia","volume":"27","author":"Pastan","year":"2009","journal-title":"J Clin Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1432-1327.1999.00214.x","article-title":"Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library","volume":"260","author":"Arends","year":"1999","journal-title":"Eur J Biochem"},{"key":"37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-1759(01)00298-8","article-title":"An improved procedure for the generation of recombinant single-chain Fv antibody fragments reacting with human CD13 on intact cells","volume":"251","author":"Fey","year":"2001","journal-title":"J Immunol Methods"},{"key":"38","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1158\/0008-5472.CAN-08-0461","article-title":"Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity","volume":"68","author":"Pastan","year":"2008","journal-title":"Cancer Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.4155\/tde.13.87","article-title":"Novel therapy based on camelid nanobodies","volume":"4","author":"Garcia-Salcedo","year":"2013","journal-title":"Ther Deliv"},{"key":"40","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1200\/JCO.2005.11.437","article-title":"Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies","volume":"23","author":"Pastan","year":"2005","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1200\/JCO.2000.18.8.1622","article-title":"Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB- 2) in patients with hematologic malignancies","volume":"18","author":"Pastan","year":"2000","journal-title":"J Clin Oncol"},{"key":"42","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.leu.2404687","article-title":"A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells","volume":"21","author":"Fey","year":"2007","journal-title":"Leukemia"},{"key":"43","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-12-3891","article-title":"Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy","volume":"19","author":"Bigner","year":"2013","journal-title":"Clin Cancer Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.2005.05869.x","article-title":"A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells","volume":"133","author":"Fey","year":"2006","journal-title":"Br J Haematol"},{"key":"45","first-page":"693","article-title":"Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB- 2)","volume":"6","author":"Kreitman","year":"2000","journal-title":"Clin Cancer Res"},{"key":"46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/jmbi.1998.1948","article-title":"A bivalent disulfide-stabilized Fv with improved antigen binding to erbB2","volume":"281","author":"Pastan","year":"1998","journal-title":"Journal of molecular biology"},{"key":"47","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/0008-5472.CAN-04-2756","article-title":"Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7","volume":"65","author":"Helfrich","year":"2005","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood-2005-07-2929","article-title":"CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia","volume":"107","author":"Helfrich","year":"2006","journal-title":"Blood"},{"key":"49","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1158\/1078-0432.CCR-04-2290","article-title":"A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia\/lymphoma","volume":"11","author":"Chen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"50","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1158\/1078-0432.CCR-06-2454","article-title":"Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv","volume":"13","author":"Vallera","year":"2007","journal-title":"Clin Cancer Res"},{"key":"51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molimm.2011.11.013","article-title":"Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor","volume":"50","author":"Muyldermans","year":"2012","journal-title":"Mol Immunol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:50:28Z","timestamp":1692287428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":51,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,6,7]]}},"alternative-id":["8710","27083001"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8710","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}